Escherichia coli pre-exposed to a sub-minimal inhibitory concentration (sub-MIC) of several antibiotics elicits an enhanced humoral response which is protective against challenges with untreated homologous and heterologous bacteria. To characterise the specificity of this response we produced murine monoclonal antibodies (MAbs) to aztreonam-treated E. coli O6:K-. This resulted in the identification of MAb MT 1F, of isotype IgG1, that recognised a 12-kDa protein component of the untreated bacterial cells. After passive transfer, the MAb displayed protective activity in mice infected with lethal doses of live E. coli O6:K- and E. coli O111:B4. In ELISA experiments the MAb cross-reacted with structures located on whole cells of E. coli O6:K-, ...
Multiresistant nosocomial pathogens often cause life-threatening infections that are sometimes untre...
Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H...
Mice were passively immunized with sera from blood donors active for rough lipopolysaccha-rides (LPS...
The binding capacity and the protective activity of three monoclonal antibodies (MAbs)-ARM 1-4, ARM ...
The murine immune response to Escherichia coli O6:K- alone or pre-exposed to 0.1 x MIC of aztreonam ...
The hypothesis of a different immunogenicity between untreated and antibiotic-treated Escherichia co...
The murine immune response to Escherichia coli exposed to subminimal inhibitory concentrations of fo...
Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mi...
Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H...
Monoclonal antibody (MAb) 12F5 reacted with 35 Escherichia coli O26 isolates and cross-reacted with ...
Four strains of E. coli, two encapsulated and two unencapsulated, were grown in the presence or abse...
A panel of eight murine monoclonal antibodies (MAbs) were produced against heat-killed Escherichia c...
We have previously described cross-reactive antilipopolysaccharide (anti-LPS), or anti-endotoxin, mo...
We have previously described cross-reactive antilipopolysaccharide (anti-LPS), or anti-endotoxin, mo...
Escherichia coli O18K5 infection of mice. monoclonal antibodies against lethal of anticapsule and an...
Multiresistant nosocomial pathogens often cause life-threatening infections that are sometimes untre...
Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H...
Mice were passively immunized with sera from blood donors active for rough lipopolysaccha-rides (LPS...
The binding capacity and the protective activity of three monoclonal antibodies (MAbs)-ARM 1-4, ARM ...
The murine immune response to Escherichia coli O6:K- alone or pre-exposed to 0.1 x MIC of aztreonam ...
The hypothesis of a different immunogenicity between untreated and antibiotic-treated Escherichia co...
The murine immune response to Escherichia coli exposed to subminimal inhibitory concentrations of fo...
Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mi...
Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H...
Monoclonal antibody (MAb) 12F5 reacted with 35 Escherichia coli O26 isolates and cross-reacted with ...
Four strains of E. coli, two encapsulated and two unencapsulated, were grown in the presence or abse...
A panel of eight murine monoclonal antibodies (MAbs) were produced against heat-killed Escherichia c...
We have previously described cross-reactive antilipopolysaccharide (anti-LPS), or anti-endotoxin, mo...
We have previously described cross-reactive antilipopolysaccharide (anti-LPS), or anti-endotoxin, mo...
Escherichia coli O18K5 infection of mice. monoclonal antibodies against lethal of anticapsule and an...
Multiresistant nosocomial pathogens often cause life-threatening infections that are sometimes untre...
Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H...
Mice were passively immunized with sera from blood donors active for rough lipopolysaccha-rides (LPS...